17371827

Source:http://linkedlifedata.com/resource/pubmed/id/17371827

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019169, umls-concept:C0034284, umls-concept:C0441655, umls-concept:C0596988, umls-concept:C1533691
pubmed:issue	6
pubmed:dateCreated	2007-5-22
pubmed:abstractText	The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro. Most drug-resistant mutants, including multidrug-resistant strains, remained sensitive to tenofovir and PMEO-DAPym. Therefore, the latter molecule deserves further evaluation for the treatment of HBV infection.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-11960502, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-12069973, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-12198665, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-12606735, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-12627352, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-12891527, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-14642631, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15328117, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15382118, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15451174, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15728921, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15905671, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15915463, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-15987916, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16168522, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16218172, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16230074, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16338024, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16405720, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16495257, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16611195, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16716414, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16762627, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16801428, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16871562, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16871563, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-16941700, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-17030194, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-17239478, http://linkedlifedata.com/resource/pubmed/commentcorrection/17371827-9371374
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0315061
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidine Nucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0066-4804
pubmed:author	pubmed-author:BrunelleM NMN, pubmed-author:KOLBL CLC, pubmed-author:LuciforaJJ, pubmed-author:NeytsJJ, pubmed-author:UTINAIaIa, pubmed-author:VilletSS, pubmed-author:ZoulimFF
pubmed:issnType	Print
pubmed:volume	51
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2240-3
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:17371827-Adenine, pubmed-meshheading:17371827-Antiviral Agents, pubmed-meshheading:17371827-Cell Line, Tumor, pubmed-meshheading:17371827-Drug Resistance, Multiple, Viral, pubmed-meshheading:17371827-Hepatitis B, Chronic, pubmed-meshheading:17371827-Hepatitis B virus, pubmed-meshheading:17371827-Humans, pubmed-meshheading:17371827-Microbial Sensitivity Tests, pubmed-meshheading:17371827-Mutation, pubmed-meshheading:17371827-Phosphonic Acids, pubmed-meshheading:17371827-Pyrimidine Nucleosides, pubmed-meshheading:17371827-Reverse Transcriptase Inhibitors, pubmed-meshheading:17371827-Virus Replication
pubmed:year	2007
pubmed:articleTitle	In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.
pubmed:affiliation	INSERM, U871, 151 Cours Albert Thomas, 69424 Lyon cedex 03, France.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't